Skip Navigation

Cardiovascular Research 2006 69(3):562-573; doi:10.1016/j.cardiores.2005.12.002
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nagase, H.
Right arrow Articles by Murphy, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagase, H.
Right arrow Articles by Murphy, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, European Society of Cardiology

Structure and function of matrix metalloproteinases and TIMPs

Hideaki Nagasea,*, Robert Vissea and Gillian Murphyb

aDepartment of Matrix Biology, Kennedy Institute of Rheumatology Division, Faculty of Medicine, Imperial College London, 1 Aspenlea Road, London W6 8LH, UK
bDepartment of Oncology, University of Cambridge, Cambridge Institute for Medical, Research, Hills Road, Cambridge, CB2 2XY, UK

* Corresponding author. Tel.: +44 20 8383 4488; fax: +44 20 8383 4994. Email address: h.nagase{at}imperial.ac.uk

Matrix metalloproteinases (MMPs), also called matrixins, function in the extracellular environment of cells and degrade both matrix and non-matrix proteins. They play central roles in morphogenesis, wound healing, tissue repair and remodelling in response to injury, e.g. after myocardial infarction, and in progression of diseases such as atheroma, arthritis, cancer and chronic tissue ulcers. They are multi-domain proteins and their activities are regulated by tissue inhibitors of metalloproteinases (TIMPs). This review introduces the members of the MMP family and discusses their domain structure and function, proenyme activation, the mechanism of inhibition by TIMPs and their significance in physiology and pathology.


Time for primary review 12 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
L. Troeberg, K. Fushimi, R. Khokha, H. Emonard, P. Ghosh, and H. Nagase
Calcium pentosan polysulfate is a multifaceted exosite inhibitor of aggrecanases
FASEB J, October 1, 2008; 22(10): 3515 - 3524.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. A. Zavadzkas, R. A. Plyler, S. Bouges, C. N. Koval, W. T. Rivers, C. U. Beck, E. I. Chang, R. E. Stroud, R. Mukherjee, and F. G. Spinale
Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1394 - H1402.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. G. Spinale, C. N. Koval, A. M. Deschamps, R. E. Stroud, and J. S. Ikonomidis
Dynamic Changes in Matrix Metalloprotienase Activity Within the Human Myocardial Interstitium During Myocardial Arrest and Reperfusion
Circulation, September 30, 2008; 118(14_suppl_1): S16 - S23.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. Almholt, A. Juncker-Jensen, O. D. Laerum, K. Dano, M. Johnsen, L. R. Lund, and J. Romer
Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model
Mol. Cancer Ther., September 1, 2008; 7(9): 2758 - 2767.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. D. Humphrey
Mechanisms of Arterial Remodeling in Hypertension: Coupled Roles of Wall Shear and Intramural Stress
Hypertension, August 1, 2008; 52(2): 195 - 200.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-A. Cho, P. Osenkowski, H. Zhao, S. Kim, M. Toth, K. Cole, A. Aboukameel, A. Saliganan, L. Schuger, R. D. Bonfil, et al.
The Inactive 44-kDa Processed Form of Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Enhances Proteolytic Activity via Regulation of Endocytosis of Active MT1-MMP
J. Biol. Chem., June 20, 2008; 283(25): 17391 - 17405.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. J. Lockwood, C. Oner, Y. H. Uz, U. A. Kayisli, S. J. Huang, L. F. Buchwalder, W. Murk, E. F. Funai, and F. Schatz
Matrix Metalloproteinase 9 (MMP9) Expression in Preeclamptic Decidua and MMP9 Induction by Tumor Necrosis Factor Alpha and Interleukin 1 Beta in Human First Trimester Decidual Cells
Biol Reprod, June 1, 2008; 78(6): 1064 - 1072.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Malla, E. Berg, L. Uhlin-Hansen, and J.-O. Winberg
Interaction of Pro-matrix Metalloproteinase-9/Proteoglycan Heteromer with Gelatin and Collagen
J. Biol. Chem., May 16, 2008; 283(20): 13652 - 13665.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Sauter, A. Rosenberger, L. Beckmann, S. Kropp, K. Mittelstrass, M. Timofeeva, G. Wolke, A. Steinwachs, D. Scheiner, E. Meese, et al.
Matrix Metalloproteinase 1 (MMP1) Is Associated with Early-Onset Lung Cancer
Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1127 - 1135.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
B. Tucker, H. Klassen, L. Yang, D. F. Chen, and M. J. Young
Elevated MMP Expression in the MRL Mouse Retina Creates a Permissive Environment for Retinal Regeneration
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1686 - 1695.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Morikawa, N. Ohara, Q. Xu, K. Nakabayashi, D. A. DeManno, K. Chwalisz, S. Yoshida, and T. Maruo
Selective progesterone receptor modulator asoprisnil down-regulates collagen synthesis in cultured human uterine leiomyoma cells through up-regulating extracellular matrix metalloproteinase inducer
Hum. Reprod., April 1, 2008; 23(4): 944 - 951.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.